Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients
NCT00548691 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 513
Last updated 2018-02-20
Summary
The Objective of this study is to study the safety of FCM in patients with anemia caused by chronic kidney failure
Conditions
Interventions
- DRUG
-
Ferric Carboxymaltose
- DRUG
-
Standard Medical Care (SMC)
Sponsors & Collaborators
-
American Regent, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2009-01-31
- Completion
- 2009-07-31
Countries
- United States
Study Locations
More Related Trials
-
Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment
NCT00935831 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
NCT00830037 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease
NCT04059913 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
NCT01750190 ·Status: COMPLETED ·Phase: PHASE3
-
Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
NCT04239391 ·Status: UNKNOWN ·Phase: PHASE3
-
A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
NCT07187401 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of FG-4592 in Subjects With Chronic Kidney Disease in China
NCT01599507 ·Status: COMPLETED ·Phase: PHASE2
-
Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
NCT01942460 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
NCT04649411 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of GBT021601 in Participants With Renal Impairment
NCT05878704 ·Status: TERMINATED ·Phase: PHASE1
-
A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin
NCT00456053 ·Status: COMPLETED ·Phase: PHASE2
-
FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis
NCT02652819 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104
NCT05476887 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
NCT02174627 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects
NCT03418168 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia
NCT01235936 ·Status: COMPLETED ·Phase: PHASE2
-
Peginesatide for Anemia in Chronic Hemodialysis Patients
NCT00228449 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
NCT01151592 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients
NCT02570854 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease
NCT02019719 ·Status: COMPLETED ·Phase: PHASE2
-
A Crossover Safety Study of Ferumoxytol Versus Placebo
NCT00255450 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment
NCT01414075 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
NCT05035641 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection
NCT00807794 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia
NCT01244763 ·Status: COMPLETED ·Phase: PHASE2